You are here: Industry Insights > Diabetes

News List

A new molecule to improve treatment for type 2 diabetes and non-alcoholic fatty liver disease firstwordpharma
April 11, 2019
A new molecule to improve treatment for type 2 diabetes and non-alcoholic fatty liver disease.
Sanofi plans sales layoffs—again—in primary care, diabetes fiercepharma
April 04, 2019
Sanofi has been hit hard by pricing pressure in diabetes, and now the drugmaker’s U.S. sales force is set for another round of job cuts.
Cigna's Express Scripts to cap out-of-pocket insulin costs at $25 per month in US firstwordpharma
April 04, 2019
Health insurer Cigna and its pharmacy benefit manager (PBM) arm Express Scripts announced Wednesday the launch of a programme in the US designed to ensure that eligible patients with diabetes in participating plans pay no more than $25 for a 30-day supply
Fresh off new Farxiga data, AstraZeneca diabetes push points up cardiovascular, renal risks fiercepharma
April 02, 2019
AstraZeneca has been pumping dollars into studying its Type 2 diabetes drugs and their ability to stave off complications like heart disease and kidney problems……
Pfizer Study Finds Progress in Combating Fatty Liver firstwordpharma
March 28, 2019
Pfizer unveiled mid-stage study results illustrating that a drug that prevents the body from metabolising fructose significantly reduced liver fat, Bloomberg reported Wednesday.
Gelesis Presents Expanded Data Showing Impact of Gelesis100 Hydrogel on Patients with Prediabetes, Untreated Diabetes, and Elevated Insulin firstwordpharma
March 26, 2019
Gelesis, a biotechnology company developing first-in-class mechanotherapeutics to treat obesity and other chronic diseases related to……
FDA Approves Sunosi (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea drugs
March 21, 2019
Jazz Pharmaceuticals plc today announced that the U.S. Food and Drug Administration (FDA) approved Sunosi (solriamfetol) to improve wakefulness in adult patients with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea (OSA)
EastGate Biotech Signs Strategic Alliance Agreement with MJ Biopharm for Insulin API Supply pharmpacpeutical-technology
March 20, 2019
EastGate Biotech Corp., a pharmaceutical company that focuses on innovative technological developments specifically in insulin drug delivery for the treatment of Type 2 diabetes, entered into a long term strategic alliance with MJ Biopharm (www.mjgroup.c
FDA Warns Homeopathic Company About Illegal Product Claims drugs
March 20, 2019
Nutra Pharma Corp. has been warned about illegal marketing of unapproved homeopathic products with claims that they can treat addiction and chronic pain from serious conditions such as cancer, diabetes, shingles, and fibromyalgia, the U.S. Food and Drug A
Diabetes drug effective against heart failure in wide spectrum of patients worldpharmanews
March 19, 2019
The cardiovascular benefits of the diabetes drug dapagliflozin extend across a wide spectrum of patients and are especially pronounced in those with reduced ejection fraction...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 37 38 Next page